From: The impact of pharmacokinetic gene profiles across human cancers
#T | #E | #N | TSSa | Age | Sex | Stage | Grade | LIb | Smoke statusc | Tumor specificd | |
---|---|---|---|---|---|---|---|---|---|---|---|
GBM | 394 | 154 | 0 | ● | ● | ● | ● | ||||
OV | 573 | 262 | 0 | ● | ● | ● | ● | ● | ● | ||
BRCA | 905 | 817 | 104 | ● | ● | ● | ● | ||||
UCEC | 473 | 333 | 5 | ● | ● | ● | ● | ||||
KIRC | 505 | 470 | 65 | ● | ● | ● | ● | ● | |||
COAD | 424 | 192 | 0 | ● | ● | ● | ● | ● | ● | ||
READ | 168 | 71 | 0 | ● | ● | ● | ● | ● | ● | ||
BLCA | 139 | 96 | 13 | ● | ● | ● | ● | ● | |||
LUAD | 447 | 353 | 55 | ● | ● | ● | ● | ||||
LUSC | 404 | 220 | 16 | ● | ● | ● | ● | ||||
HNSC | 409 | 303 | 37 | ● | ● | ● | ● | ● | ● |